Status:
COMPLETED
Comparison of QoR-15 in Laparoscopic Cholecystectomy: Sugammadex vs. Neostigmine
Lead Sponsor:
Seoul National University Bundang Hospital
Conditions:
Neuromuscular Blockade Reversal Agent
Sugammadex
Eligibility:
All Genders
20-70 years
Phase:
PHASE4
Brief Summary
The quality of recovery in patients who were reversed neuromuscular blockade by using Sumamadex and Neostigmine in laparoscopic cholecystectomy was compared through the QoR(Quality of Recovery)-15 que...
Detailed Description
Quality of Recovery questionnaire includes five details (Emotional status, Physical comfort, Physiological support, Physical independece, Pain), and is a proven method of reliability, consistency and ...
Eligibility Criteria
Inclusion
- patients who underwent laparoscopic cholecystectomy aged 20-70
Exclusion
- neuromuscular disease
- allergy to rocuronium, sugammadex, neostigmine
- cognitive impairment ( disable to answer the questionnaire )
- refuse to participate
Key Trial Info
Start Date :
February 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 21 2020
Estimated Enrollment :
77 Patients enrolled
Trial Details
Trial ID
NCT04332627
Start Date
February 24 2020
End Date
May 21 2020
Last Update
December 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea, 13620